Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

308

HTML

3251

Figures (1-2)

239

Tables (1-8)

217

Sum=4015

Jan 21, 2010 (publication date) through Jan 2, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 21, 2010; 16(3): 330-338
Published online Jan 21, 2010. doi: 10.3748/wjg.v16.i3.330

Table 8 Correlation between peritoneal recurrence and multigene methylation and also the CK19 expression results in group B

	*Multigene methylation (CHFR, E-cadherin, BNIP3)*		P-value	CK19		P-value
	Less than 2 genes	2 or more genes	P-value	Negative	Positive	P-value
Peritoneal recurrence
Positive	0	2	< 0.05	1	1	0.943
Negative	23	3		10	9

Citation: Hiraki M, Kitajima Y, Sato S, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World J Gastroenterol 2010; 16(3): 330-338
URL: https://www.wjgnet.com/1007-9327/full/v16/i3/330.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i3.330